A recent meta-analysis has shown that pancreatic elastase test has a combined sensitivity of 0.77 in detecting exocrine pancreatic insufficiency (Vanga, Rohini R. et al. Clinical Gastroenterology and Hepatology, 2018). What's the impact of this reported sensitivity in current clinical practice? Would a test with higher sensitivity make a positive and significant impact on time-to-diagnosis?